Showing results (71-80 of 193) with videos related to
Sort By:
Pageof 20
Journal of Clinical Pharmacology|September 25, 2020
Absolute Bioavailability of Microdosed Midazolam After Buccal Administration Is Dependent on Buccal Exposure TimeJana Grass, Peter Rose, Jürgen Burhenne, et al.British Journal of Clinical Pharmacology|June 22, 2019
Simultaneous phenotyping of CYP2E1 and CYP3A using oral chlorzoxazone and midazolam microdosesNicolas Hohmann, Antje Blank, Jürgen Burhenne, et al.British Journal of Clinical Pharmacology|December 24, 2010
The NK₁ receptor antagonist aprepitant does not alter the pharmacokinetics of high-dose melphalan chemotherapy in patients with multiple myelomaGerlinde Egerer, Kathrin Eisenlohr, Martina Gronkowski, et al.British Journal of Clinical Pharmacology|January 16, 2015
Midazolam microdose to determine systemic and pre-systemic metabolic CYP3A activity in humansNicolas Hohmann, Franziska Kocheise, Alexandra Carls, et al.Clinical Pharmacology and Therapeutics|April 6, 2007
Pharmacokinetics of 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol (CTHC) after intravenous administration of CTHC in healthy human subjectsA Glaz-Sandberg, L Dietz, H Nguyen, et al.Neonatology|November 2, 2018
Prescription Drug Shortages: Impact on Neonatal Intensive CareVictoria C Ziesenitz, Erin Fox, Mark Zocchi, et al.Basic & Clinical Pharmacology & Toxicology|March 28, 2019
Decreased Cytochrome P450 3A activity in palliative patients with haematological diseases: Potential impact on supportive drug therapiesMarcus J P Geist, Nelly Siller, Gerlinde Egerer, et al.Clinical and Translational Science|August 17, 2024
Dose-dependent induction of CYP3A activity by St. John's wort alone and in combination with rifampinNicolas Hohmann, Anna S Friedrichs, Jürgen Burhenne, et al.Journal of Pharmaceutical Sciences|March 24, 2020
New Insights Into the Pharmacokinetics of Vancomycin After Oral and Intravenous Administration: An Investigation in Beagle DogsMax Sauter, Philipp Uhl, Andreas D Meid, et al.Journal of Clinical Pharmacology|November 25, 2020
Application of Microdosed Intravenous Omeprazole to Determine Hepatic CYP2C19 ActivityMazyar Mahmoudi, Kathrin I Foerster, Jürgen Burhenne, et al.Pageof 20